Aim: Comparison of two gated SPECT analysis tools gated SPECT quantification (GSQ) and emory cardiac toolbox (ECT) in patients with coronary artery disease (CAD) and severely impaired left ventricular function (preoperative: EF <35% by cardiac catheter)...
Keywords: GatedSPECT, kardiale Volumetrie, kardiale MRT, Myokardnarbe, koronare Herzerkrankung, Herzinsuffizienz
01/2006 | Nuklearmedizin, SchattauerAim: To determine the long-term prognostic value of SPECT myocardial perfusion imaging (MPI) for the occurrence of cardiovascular events in diabetic patients...
Keywords: Diabetes mellitus, koronare Herzkrankheit, Myokardischämie, Prognose; Myokardperfusion, SPECT
01/2006 | Nuklearmedizin, SchattauerAIM: Hyperhomocysteinaemia (Hhcy) is known to be an independent risk factor for vascular disease. Coronary flow reserve (CFR) measured by positron emission tomography (PET) is a sensitive method to monitor the effects of pharmacologic interventions in Hhcy...
Keywords: Homocystein, koronare Flussreseve, koronare Herzkrankheit, PET
01/2006 | Nuklearmedizin, SchattauerAIM: In patients with stable angina pectoris both morphological and functional information about the coronary artery tree should be present before revascularization therapy is performed...
Keywords: Myokardszintigraphie, SPECT, 64-Zeilen-CT-Angiographie, invasive Koronarangiographie, koronare Herzerkrankung, stabile Angina pectoris
01/2007 | Nuklearmedizin, SchattauerThe antiplatelet effect of aspirin varies individually. This study evaluated whether the antiplatelet effect of aspirin associates with polymorphisms in the genes coding for cyclo-oxygenase-1 (COX-1) and several platelet glycoprotein (GP) receptors in patients with stable coronary artery disease (CAD)...
Keywords: Aspirin, cyclo-oxygenase-1, genotype, glycoprotein VI, coronary artery disease
00/0000 | Thrombosis and Haemostasis, SchattauerNo prospective data demonstrating an association between the 11377 C > G adiponectin gene promoter variant and cardiovascular risk are available...
Keywords: coronary artery disease, angiography, risk factors, cytokines, epidemiology
03/2007 | Thrombosis and Haemostasis, Schattauer
Keywords: coronary artery disease, C-reactive protein, inflammation, percutaneous coronary intervention, stent
04/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Keywords: African-Brazilians, coronary artery disease, paraoxonase, Polymorphism
07/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: koronare Herzkrankheit, Magnetfeldkarten, Magnetokardiographie, QT-Intervall, Signalanalyse
07/2006 | Biomedizinische Technik, Walter de GruyterAntibody titer against malondialdehyde (MDA)-modified low-density lipoprotein (LDL) has been found to be associated with atherosclerosis, but it has not been established whether it would detect subjects with coronary artery disease (CAD)...
Keywords: antibodies, coronary artery disease, high-density lipoprotein cholesterol, malondialdehyde-modified low-density lipoprotein, receiver-operating characteristic analysis
04/2005 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: coronary artery disease, paraoxonase-1 (PON1) activity, PON1Q192R phenotype
10/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: apolipoprotein (apo), apoB/apoAI ratio, cholesterol, coronary artery disease, lipoprotein(a)
08/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: atherosclerosis, coronary artery disease, diabetes, hydroperoxides, oxidative stress, risk factors
03/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterZusammenfassung Asymmetrisches Dimethylarginin (ADMA) ist eine endogen produzierte Aminosure, die alle drei Isoformen der Stickoxid-Synthase inhibiert...
Keywords: Asymmetrisches Dimethylarginin (ADMA), Atherosklerose, biomarker, endotheliale Dysfunktion, kardiovaskulres Risiko, Stickstoffmonoxid, atherosclerosis, aymmetric dimethyl arginine (ADMA), cardiovascular risk, coronary artery disease, endothelial dysfunction, nitric oxide
06/2007 | LaboratoriumsMedizin, Walter de GruyterKeywords: apolipoprotein B, coronary artery disease, genotypes, 5? ins/del, lipids, Polymorphism, 3? VNTR
03/2008 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: angiotensin I-converting enzyme gene (ACE), atherosclerosis, coronary artery disease, Polymorphism
04/2008 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: apolipoprotein E, coronary artery disease, genetic susceptibility, Mexican population, Polymorphism
04/2008 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: apolipoprotein B, cholesterol, coronary artery disease, Diabetes mellitus, lipoprotein(a)
05/2008 | Clinical Chemical Laboratory Medicine, Walter de GruyterNo available
Keywords: chronic inflammation, coronary artery disease, Matrix metalloproteinase, myocardial infarction
00/0000 | Clinical Chemical Laboratory Medicine, Walter de GruyterExperimental and observational studies support a role of plasma homocysteine levels (tHcy) in coronary artery disease (CAD)...
Keywords: cardiac dysfunction, coronary artery disease, homocysteine
12/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: coronary artery disease, C-reactive protein, Polymorphism, resistin
11/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Keywords: advanced glycation end products, coronary artery disease, disease severity, Euro-Brazilians, risk factor, single nucleotide polymorphism, type 2 diabetes
10/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Keywords: Body mass index, CD36, coronary artery disease, obesity, polymorphisms
10/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter